Neukio Biotherapeutics and Unitree Robotics have secured fresh funding.
Neukio Biotherapeutics nets $40m led by LAV
Neukio Biotherapeutics Co, Ltd, a biotech firm that specialises in the R&D of immune cell drugs, has raised $40 million in its angel round led by Lilly Asia Ventures (LAV).
